Cargando…

PRMDA: personalized recommendation-based MiRNA-disease association prediction

Recently, researchers have been increasingly focusing on microRNAs (miRNAs) with accumulating evidence indicating that miRNAs serve as a vital role in various biological processes and dysfunctions of miRNAs are closely related with human complex diseases. Predicting potential associations between mi...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Zhu-Hong, Wang, Luo-Pin, Chen, Xing, Zhang, Shanwen, Li, Xiao-Fang, Yan, Gui-Ying, Li, Zheng-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689632/
https://www.ncbi.nlm.nih.gov/pubmed/29156742
http://dx.doi.org/10.18632/oncotarget.20996
_version_ 1783279422088937472
author You, Zhu-Hong
Wang, Luo-Pin
Chen, Xing
Zhang, Shanwen
Li, Xiao-Fang
Yan, Gui-Ying
Li, Zheng-Wei
author_facet You, Zhu-Hong
Wang, Luo-Pin
Chen, Xing
Zhang, Shanwen
Li, Xiao-Fang
Yan, Gui-Ying
Li, Zheng-Wei
author_sort You, Zhu-Hong
collection PubMed
description Recently, researchers have been increasingly focusing on microRNAs (miRNAs) with accumulating evidence indicating that miRNAs serve as a vital role in various biological processes and dysfunctions of miRNAs are closely related with human complex diseases. Predicting potential associations between miRNAs and diseases is attached considerable significance in the domains of biology, medicine, and bioinformatics. In this study, we developed a computational model of Personalized Recommendation-based MiRNA-Disease Association prediction (PRMDA) to predict potential related miRNA for all diseases by implementing personalized recommendation-based algorithm based on integrated similarity for diseases and miRNAs. PRMDA is a global method capable of prioritizing candidate miRNAs for all diseases simultaneously. Moreover, the model could be applied to diseases without any known associated miRNAs. PRMDA obtained AUC of 0.8315 based on leave-one-out cross validation, which demonstrated that PRMDA could be regarded as a reliable tool for miRNA-disease association prediction. Besides, we implemented PRMDA on the HMDD V1.0 and HMDD V2.0 databases for three kinds of case studies about five important human cancers in order to test the performance of the model from different perspectives. As a result, 92%, 94%, 88%, 96% and 88% out of the top 50 candidate miRNAs predicted by PRMDA for Colon Neoplasms, Esophageal Neoplasms, Lymphoma, Lung Neoplasms and Breast Neoplasms, respectively, were confirmed by experimental reports.
format Online
Article
Text
id pubmed-5689632
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-56896322017-11-17 PRMDA: personalized recommendation-based MiRNA-disease association prediction You, Zhu-Hong Wang, Luo-Pin Chen, Xing Zhang, Shanwen Li, Xiao-Fang Yan, Gui-Ying Li, Zheng-Wei Oncotarget Research Paper Recently, researchers have been increasingly focusing on microRNAs (miRNAs) with accumulating evidence indicating that miRNAs serve as a vital role in various biological processes and dysfunctions of miRNAs are closely related with human complex diseases. Predicting potential associations between miRNAs and diseases is attached considerable significance in the domains of biology, medicine, and bioinformatics. In this study, we developed a computational model of Personalized Recommendation-based MiRNA-Disease Association prediction (PRMDA) to predict potential related miRNA for all diseases by implementing personalized recommendation-based algorithm based on integrated similarity for diseases and miRNAs. PRMDA is a global method capable of prioritizing candidate miRNAs for all diseases simultaneously. Moreover, the model could be applied to diseases without any known associated miRNAs. PRMDA obtained AUC of 0.8315 based on leave-one-out cross validation, which demonstrated that PRMDA could be regarded as a reliable tool for miRNA-disease association prediction. Besides, we implemented PRMDA on the HMDD V1.0 and HMDD V2.0 databases for three kinds of case studies about five important human cancers in order to test the performance of the model from different perspectives. As a result, 92%, 94%, 88%, 96% and 88% out of the top 50 candidate miRNAs predicted by PRMDA for Colon Neoplasms, Esophageal Neoplasms, Lymphoma, Lung Neoplasms and Breast Neoplasms, respectively, were confirmed by experimental reports. Impact Journals LLC 2017-09-18 /pmc/articles/PMC5689632/ /pubmed/29156742 http://dx.doi.org/10.18632/oncotarget.20996 Text en Copyright: © 2017 You et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
You, Zhu-Hong
Wang, Luo-Pin
Chen, Xing
Zhang, Shanwen
Li, Xiao-Fang
Yan, Gui-Ying
Li, Zheng-Wei
PRMDA: personalized recommendation-based MiRNA-disease association prediction
title PRMDA: personalized recommendation-based MiRNA-disease association prediction
title_full PRMDA: personalized recommendation-based MiRNA-disease association prediction
title_fullStr PRMDA: personalized recommendation-based MiRNA-disease association prediction
title_full_unstemmed PRMDA: personalized recommendation-based MiRNA-disease association prediction
title_short PRMDA: personalized recommendation-based MiRNA-disease association prediction
title_sort prmda: personalized recommendation-based mirna-disease association prediction
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689632/
https://www.ncbi.nlm.nih.gov/pubmed/29156742
http://dx.doi.org/10.18632/oncotarget.20996
work_keys_str_mv AT youzhuhong prmdapersonalizedrecommendationbasedmirnadiseaseassociationprediction
AT wangluopin prmdapersonalizedrecommendationbasedmirnadiseaseassociationprediction
AT chenxing prmdapersonalizedrecommendationbasedmirnadiseaseassociationprediction
AT zhangshanwen prmdapersonalizedrecommendationbasedmirnadiseaseassociationprediction
AT lixiaofang prmdapersonalizedrecommendationbasedmirnadiseaseassociationprediction
AT yanguiying prmdapersonalizedrecommendationbasedmirnadiseaseassociationprediction
AT lizhengwei prmdapersonalizedrecommendationbasedmirnadiseaseassociationprediction